Showing results (461-470 of 476) with videos related to

Sort By:
Pageof 48
British Journal of Haematology|May 25, 2023
A venetoclax and azacitidine bridge-to-transplant strategy for NPM1-mutated acute myeloid leukaemia in molecular failureC Sartor, L Brunetti, E Audisio, et al.
European Journal of Human Genetics : EJHG|January 15, 1999
Gene/longevity association studies at four autosomal loci (REN, THO, PARP, SOD2)G De Benedictis, L Carotenuto, G Carrieri, et al.
Clinical Nutrition (Edinburgh, Scotland)|August 8, 2015
Impact of diet and nutraceutical supplementation on inflammation in elderly people. Results from the RISTOMED study, an open-label randomized control trialR Ostan, M C Béné, L Spazzafumo, et al.
Leukemia|November 7, 2008
The molecular anatomy of the FIP1L1-PDGFRA fusion geneC Walz, J Score, J Mix, et al.
Leukemia|May 18, 2007
WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemiaD Cilloni, F Messa, G Martinelli, et al.
The Pharmacogenomics Journal|May 16, 2012
Profiling of drug-metabolizing enzymes/transporters in CD33+ acute myeloid leukemia patients treated with Gemtuzumab-Ozogamicin and Fludarabine, Cytarabine and IdarubicinI Iacobucci, A Lonetti, A Candoni, et al.
Experimental Gerontology|February 4, 2014
Immune parameters identify Italian centenarians with a longer five-year survival independent of their health and functional statusL Bucci, R Ostan, E Giampieri, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1996
Successful immunosenescence and the remodelling of immune responses with ageingC Franceschi, D Monti, D Barbieri, et al.
Cell Death and Differentiation|May 8, 2004
The different apoptotic potential of the p53 codon 72 alleles increases with age and modulates in vivo ischaemia-induced cell deathM Bonafé, S Salvioli, C Barbi, et al.
Leukemia|September 18, 2009
Different isoforms of the B-cell mutator activation-induced cytidine deaminase are aberrantly expressed in BCR-ABL1-positive acute lymphoblastic leukemia patientsI Iacobucci, A Lonetti, F Messa, et al.
Pageof 48